SEC

Published September 23, 2026

Exhibit 99.1 - SEC.gov

Read the full story at SEC

Exhibit 99.1. Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations.